Comparison of Bayesian survival analysis and Cox regression analysis in simulated and breast cancer data sets

Expert Systems with Applications

Volumn 36, Issue 8, 2009, Pages 11341-11346

  Omurlu, Imran Kurt ^a   Ozdamar, Kazim ^b   Ture, Mevlut ^c  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Bayesian survival; Breast cancer; Cox regression; Markov Chain Monte Carlo; Simulation; Survival

Indexed keywords

BAYESIAN SURVIVAL; BREAST CANCER; COX REGRESSION; MARKOV CHAIN MONTE CARLO; SIMULATION; SURVIVAL;

BAYESIAN NETWORKS; BIOINFORMATICS; CORROSION RESISTANT ALLOYS; FORECASTING; MARKOV PROCESSES; MONTE CARLO METHODS; PATIENT MONITORING; REGRESSION ANALYSIS; UNCERTAIN SYSTEMS;

BODY FLUIDS;

EID: 67349233888     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2009.03.058     Document Type: Article

References (20)

1. Ahmed F.E., Vos P.W., and Holbert D. Modeling survival in colon cancer: A methodological review. Molecular Cancer 6 (2007) 15
2. Bender R., Augustin T., and Blettner M. Generating survival times to simulate Cox proportional hazards models. Statistics in Medicine 24 11 (2005) 1713-1723
3. Calle M.L., Hough G., Curia A., and Gómez G. Bayesian survival analysis modeling applied to sensory shelf life of foods. Food Quality and Preference 17 3-4 (2006) 307-312
4. Congdon P. Applied Bayesian modeling (2003), John Wiley & Sons, England
5. Congdon P. Bayesian statistical modelling (2006), John Wiley & Sons, England
6. Foekens J.A., Schmitt M., Van Putten W.L.J., Peters H.A., Bontenbal M., Janicke F., et al. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Research 52 (1992) 6101-6105
7. Gasparini G., Toi M., Gion M., Verderio P., Dittadi R., Hanatani M., et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. Journal of the National Cancer Institute 89 2 (1997) 139-147
8. Gelfand A.E., and Mallick B.K. Bayesian analysis of proportional hazards models built from monotone functions. Biometrics 51 3 (1995) 843-852
9. Gelman A. Posterior distribution. Encyclopedia of Environmetrics 3 (2002) 1627-1628
10. Gelman A. Prior distribution. Encyclopedia of Environmetric 3 (2002) 1627-1628
11. Hosmer D.W., and Lemeshow S. Applied survival analysis: Regression modeling of time to event data (1999), John Wiley & Sons, Canada
12. Ibrahim J.G., Chen M.H., and Sinha D. Bayesian survival analysis (2001), Springer-Verlag, New York
13. Kleinbaum D.G., and Klein M. Survival analysis: A self-learning text (1996), Springer, USA
14. Pinto A.E., Andre S., and Soares J. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: A multivariate analysis of prognostic markers in a series of 308 patients. Journal of Clinical Pathology 52 (1999) 604-611
15. Robert C.P., and Casella G. Monte Carlo statistical methods (2004), Springer, New York
16. Rowlings P.A., Williams S.F., Antman K.H., Fields K.K., Fay J.W., Reed E., et al. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA 282 (1999) 1335-1343
17. SAS Institute. (2006). Preliminary capabilities for Bayesian analysis in SAS/STATR Software, SAS Institute Inc., Cary, NC, USA.
18. Wong M.C.M., Lam K.F., and Lo E.C.M. Bayesian analysis of clustered interval-censored data. Journal of Dental Research 84 9 (2005) 817-821
19. Yin, G., & Ibrahim, J. G. (2006). Bayesian transformation hazard model. In Proceedings of the second Lehmann symposium-optimality, IMS lecture notes-monograph series (Vol. 49, pp. 170-182).
20. Yu H., Giai M., Diamandis E.P., Katsaros D., Sutherland D.J., Levesque M.A., et al. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Research 55 10 (1995) 2104-2110